Published in J Vasc Surg on December 22, 2016
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg (2005) 2.83
Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy (2004) 2.69
Stromal vascular progenitors in adult human adipose tissue. Cytometry A (2010) 2.53
Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A (2010) 2.49
Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg (2010) 2.47
Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev (2012) 2.47
Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J (2009) 2.21
Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A (2007) 2.01
Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci U S A (2011) 1.94
Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med (2007) 1.84
Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci U S A (2006) 1.74
A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J (2011) 1.70
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med (2009) 1.62
Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. World J Stem Cells (2011) 1.61
Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J (2011) 1.52
Technology insight: the evolution of tissue-engineered vascular grafts--from research to clinical practice. Nat Clin Pract Cardiovasc Med (2007) 1.50
Considerations for tissue-engineered and regenerative medicine product development prior to clinical trials in the United States. Tissue Eng Part B Rev (2010) 1.29
Pericyte-based human tissue engineered vascular grafts. Biomaterials (2010) 1.25
A seeding device for tissue engineered tubular structures. Biomaterials (2006) 1.24
Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. Int J Colorectal Dis (2008) 1.22
A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater (2009) 1.20
Power assisted liposuction to obtain adipose-derived stem cells: impact on viability and differentiation to adipocytes in comparison to manual aspiration. J Plast Reconstr Aesthet Surg (2013) 1.15
In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A (2010) 1.14
Differentiation of adipose-derived stem cells into contractile smooth muscle cells induced by transforming growth factor-beta1 and bone morphogenetic protein-4. Tissue Eng Part A (2010) 1.03
Adult stem cell-based tissue engineered blood vessels: a review. Biomaterials (2012) 1.01
Differentiation of adult stem cells into smooth muscle for vascular tissue engineering. J Surg Res (2009) 0.96
What is the greatest regulatory challenge in the translation of biomaterials to the clinic? Sci Transl Med (2012) 0.91
Manual isolation of adipose-derived stem cells from human lipoaspirates. J Vis Exp (2013) 0.88
Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation. J Transl Med (2009) 0.85
Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression. Regen Med (2014) 0.79
Adipose stromal vascular fraction cells isolated using an automated point of care system improve the patency of expanded polytetrafluoroethylene vascular grafts. Tissue Eng Part A (2013) 0.79
A cautionary tale for autologous vascular tissue engineering: impact of human demographics on the ability of adipose-derived mesenchymal stem cells to recruit and differentiate into smooth muscle cells. Tissue Eng Part A (2014) 0.79
In Vivo Functional Evaluation of Tissue-Engineered Vascular Grafts Fabricated Using Human Adipose-Derived Stem Cells from High Cardiovascular Risk Populations. Tissue Eng Part A (2016) 0.79
Strategies for reducing body fat mass: effects of liposuction and exercise on cardiovascular risk factors and adiposity. Diabetes Metab Syndr Obes (2011) 0.76